Recent Q2 2026 results showed the Health Care Benefits segment's medical benefit ratio improving to 87.4% from 89.9% a year earlier, driven by stronger government business performance, disciplined medical cost management, and the absence of prior-year premium deficiency reserves. With Q3 typically reflecting higher seasonal utilization, trader sentiment centers on whether these margin gains persist into the low-90s range amid ongoing Aetna turnaround efforts and membership shifts following the individual exchange exit. The closely contested odds around 90.5–93.5% highlight uncertainty over exact utilization trends and prior-period reserve releases ahead of the November 4 earnings release, where any beats or shortfalls could shift implied probabilities. Market-implied odds reflect real-capital consensus on these variables rather than certainties.